Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Establishing a direct laboratory access program

H B Soloway1

  • 1Associated Pathologists Laboratories, Las Vegas, NV 89119, USA.

Clinical Chemistry
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detecting false negative smears.

Acta cytologica·1997
Same author

Cost-effectiveness of p24 antigen testing in preventing transfusion transmission of human immunodeficiency virus infection.

Transfusion·1996
Same author

Commonly asked questions about hepatitis B vaccination.

MLO: medical laboratory observer·1991
Same author

The Bethesda classification system: a counterintuitive approach to data presentation.

Human pathology·1991
Same author

Confidential unit exclusion (CUE) is just another test.

Transfusion·1991
Same author

The advent of hepatitis C testing.

MLO: medical laboratory observer·1990
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
Same journal

Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

Clinical chemistry·2026
Same journal

In Reply to Reflexing NT-proBNP for sFlt-1/PlGF Ratios That Fall into the Measurement Uncertainty for Preeclampsia Risk Classification.

Clinical chemistry·2026
See all related articles

Direct Laboratory Access (DLA) allows consumers to order lab tests without a doctor, offering convenience and cost savings. This program benefits consumers and physicians by streamlining healthcare access and reducing unnecessary visits.

Area of Science:

  • Healthcare Services
  • Laboratory Medicine
  • Consumer Health

Background:

  • Physician referrals traditionally gatekeep laboratory testing.
  • Consumers seek more autonomy in managing their health.
  • Existing healthcare models can be inconvenient and costly for routine testing.

Purpose of the Study:

  • To introduce and describe the Direct Laboratory Access (DLA) program.
  • To outline the benefits of DLA for both consumers and healthcare providers.
  • To identify the market niche and revenue potential of DLA.

Main Methods:

  • The study describes the DLA program model.
  • It analyzes the advantages offered to consumers and physicians.
  • It characterizes the target demographic and economic implications for laboratories.

Related Experiment Videos

Main Results:

  • DLA empowers consumers to access laboratory testing directly.
  • Physicians save time and resources by avoiding unnecessary consultations.
  • Consumers benefit from convenient, cost-effective, and desired testing without physician visits.

Conclusions:

  • Direct Laboratory Access (DLA) provides a valuable alternative to traditional healthcare pathways for laboratory testing.
  • The program serves a specific market segment, enhancing healthcare accessibility.
  • DLA offers a supplementary revenue stream for clinical laboratories.